Mycobacterium tuberculosis requires phosphate-responsive gene regulation to resist host immunity

Infection and Immunity

Volumn 81, Issue 1, 2013, Pages 317-328

  Tischler, Anna D ^a,d   Leistikow, Rachel L ^c   Kirksey, Meghan A ^b   Voskuil, Martin I ^c   McKinney, John D ^a  

^a EPFL   (Switzerland)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; IRGM1 PROTEIN; NITRIC OXIDE SYNTHASE; PHAGOCYTE OXIDASE; PHOSPHATE; PHOSPHATE SPECIFIC TRANSPORT A1; REGX3 PROTEIN; SENX3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; IMMUNITY; IN VIVO STUDY; MALE; MOUSE; MUTANT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOSOME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, BACTERIAL; GTP-BINDING PROTEINS; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; OXIDOREDUCTASES; PHAGOCYTES; PHOSPHATES; PHOSPHOTRANSFERASES; TUBERCULOSIS; VIRULENCE;

EID: 84871868047     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01136-12     Document Type: Article

References (46)

1. Lin PL, Flynn JL. 2010. Understanding latent tuberculosis: a moving target. J. Immunol. 185:15-22.
2. van de Vosse E, Hoeve MA, Ottenhoff TH. 2004. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect. Dis. 4:739-749.
3. Cooper AM, Dalton DK, Stewart TA, Griffen JP, Russell DG, Orme IM. 1993. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J. Exp. Med. 178:2243-2248.
4. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart T, Bloom BR. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
5. Wolf AJ, Linas B, Trevejo-Nuñez GJ, Kincaid E, Tamura T, Takatsu K, Ernst JD. 2007. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179:2509-2519.
6. Flannagan RS, Cosîo G, Grinstein S. 2009. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol. 7:355-366.
7. Nathan C, Shiloh MU. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. U. S. A. 97:8841-8848.
8. Jung Y-J, LaCourse R, Ryan L, North RJ. 2002. Virulent but not aviru-lent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J. Exp. Med. 196:991-998.
9. Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD. 2004. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52:1291-1302.
10. Miller JL, Velmurugan K, Cowan MJ, Briken V. 2010. The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-α-mediated host cell apoptosis. PLoS Pathog. 6:e1000864. doi:10.1371/journal.ppat.1000864.
11. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 94:5243-5248.
12. Shenoy AR, Kim B-H, Choi H-P, Matsuzawa T, Tiwari S, MacMicking JD. 2007. Emerging themes in IFN-γ-induced macrophage immunity by the p47 and p65 GTPase families. Immunobiol. 212:771-784.
13. Tiwari S, Choi H-P, Matsuzawa T, Pypaert M, MacMicking JD. 2009. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nat. Immunol.8:907-917.
14. MacMicking JD, Taylor GA, McKinney JD. 2003. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302:654-659.
15. Ehrt S, Schnappinger D. 2009. Mycobacterial survival strategies in the phagosome: defense against host stresses. Cell. Microbiol. 11:1170-1178
16. Vandal OH, Nathan CF, Ehrt S. 2009. Acid resistance in Mycobacterium tuberculosis. J. Bacteriol. 191:4714-4721.
17. Hisert KB, Kirksey MA, Gomez JE, Sousa AO, Cox JS, Jacobs WR, Jr, Nathan CF, McKinney JD. 2004. Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening. Infect. Immun. 72:5315-5321.
18. Wanner BL. 1996. Phosphorus assimilation and control of the phosphate regulon, p 1357-1381. In Neidhardt FC (ed), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed, vol 1. ASM Press, Washington, DC.
19. Lamarche MG, Wanner BL, Crépin S, Harel J. 2008. The phosphate regulon and bacterial virulence: a regulatory network connecting phosphate homeostasis and pathogenesis. FEMS Microbiol. Rev. 32:461-473.
20. Braibant M, Gilot P, Content J. 2000. The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis. FEMS Microbiol. Rev. 24:449-467.
21. Rengarajan J, Bloom BR, Rubin EJ. 2005. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc. Natl. Acad. Sci. U. S. A. 102:8327-8332.
22. Peirs P, Lefevre P, Boarbi S, Wang XM, Denis O, Braibant M, Pethe K, Locht C, Huygen K, Content J. 2005. Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence. Infect. Immun. 73:1898-1902.
23. Rifat D, Bishai WR, Karakousis PC. 2009. Phosphate depletion: a novel trigger for Mycobacterium tuberculosis persistence. J. Infect. Dis. 200: 1126-1135.
24. Glover RT, Kriakov J, Garforth SJ, Baughn AD, Jacobs WR, Jr. 2007. The two-component regulatory system senX3-regX3 regulates phosphate-dependent gene expression in Mycobacterium smegmatis. J. Bacteriol. 189: 5495-5503.
25. Kirksey MA, Tischler AD, Siméone R, Hisert KB, Uplekar S, Guilhot C, McKinney JD. 2011. Spontaneous phthiocerol dimycocerosate-deficient variants of Mycobacterium tuberculosis are susceptible to gamma interferon-mediated immunity. Infect. Immun. 79:2829-2838.
26. Muñoz-Elías EJ, McKinney JD. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med.11:638-644.
27. Senanayake SD, Brian DA. 1995. Precise large deletions by the PCR-based overlap extension method. Mol. Biotechnol. 4:13-15.
28. Pavelka MS, Jr, Jacobs WR, Jr. 1999. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis Bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J. Bacteriol. 181:4780-4789.
29. Parish T, Stoker NG. 2000. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiol. 146:1969-1975.
30. Cox JS, Chen B, McNeil M, Jacobs WR, Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79-83.
31. Slayden RA,Barry CE, III. 2001. Analysis of the lipids of Mycobacterium tuberculosis, p 229-245. In Parish T, Stoker NG (ed), Mycobacterium tuberculosis protocols. Humana Press, Totowa, NJ.
32. Collazo CM, Yap GS, Sempowski GD, Lusby KC, Tessarollo L, Vande Woude GF, Sher A, Taylor GA. 2001. Inactivation of LRG-47 and IRG-47 reveals a family of interferon [H9253]-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194:181-187.
33. Wiegeshaus EH, McMurray DN, Grover AA, Harding GE, Smith DW. 1970. Host-parasite relationships in experimental airborne tuberculosis.III. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am. Rev. Respir. Dis. 102:422-429
34. Vandal OH, Roberts JA, Odaira T, Schnappinger D, Nathan CF, Ehrt S. 2009. Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J. Bacteriol. 191:625-631.
35. Wayne LG, Lin K-Y. 1982. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun. 37:1042-1049.
36. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
37. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol.8:369-377.
38. Manganelli R, Voskuil MI, Schoolnik GK, Smith I. 2001. The Mycobacterium tuberculosis ECF sigma factor σE: role in global gene expression and survival in macrophages. Mol. Microbiol. 41:423-437.
39. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, Taylor K, Klein E, Manjunatha E, Gonzales J, Lee EG, Park SK, Raleigh JA, Cho SN, McMurray DN, Flynn JL, Barry CE, III. 2008. Tuberculosis granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76:2333-2340.
40. Himpens S, Locht C, Supply P. 2000. Molecular characterization of the mycobacterial SenX3-RegX3 two-component system: evidence for auto-regulation. Microbiol. 146:3091-3098.
41. Brauer MJ, Huttenhower C, Airoldi EM, Rosenstein R, Matese JC, Gresham D, Boer VM, Troyanskaya OG, Botstein D. 2008. Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeast. Mol. Biol. Cell 19:352-367.
42. Parish T, Smith DA, Roberts G, Betts J, Stoker NG. 2003. The senX3-regX3 two-component regulatory system of Mycobacterium tuberculosis is required for virulence. Microbiol. 149:1423-1435.
43. Bitter W, Houben ENG, Bottai D, Brodin P, Brown EJ, Cox JS, Derbyshire KM, Fortune SM, Gao Liu L-YJ, Gey van Pittius NC, Pym AS, Rubin EJ, Sherman DS, Cole ST, Brosch R 2009. Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog. 5:e1000507. doi:10.1371/journal.ppat.1000507.
44. Alonso S, Pethe K, Russell DG, Purdy GE. 2007. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl. Acad. Sci. U. S. A. 104:6031-6036.
45. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. 2007. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J. Leukoc. Biol. 82:934-945.
46. Hsieh Y-J, Wanner BL. 2010. Global regulation by the seven-component Pi signaling system. Curr. Opin. Microbiol. 13:198-203.